NCT05525949

Visual Perceptual Learning Based Digital Therapeutics for Visual Field Defect After Stroke

Treatment of Homonymous Visual Loss With Digital Therapeutics, VIVID Brain, Visual Perceptual Learning Device (HOGWAND Trial) : Multi Center, Randomized, Single-blind (Evaluator), Superiority Prove, Prospective Confirmatory Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 93 (actual)
• Sponsor: Nunaps Inc · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the efficacy of visual perceptual learning for the treatment of visual field defect caused by brain disease. Half of participants will receive visual perceptual training using the VIVID Brain. The other half will not receive any training because there is no standard treatment for visual field defect caused by brain disease.

Conditions

• Visual Fields Hemianopsia
• Hemianopsia, Homonymous

Interventions

Type	Name	Description
DEVICE	VIVID Brain	Participants receive visual perceptual training using the VIVID Brain software.
OTHER	No-treatment Control	No-treatment is administered during control period.

Timeline

• Start date: 2022-10-19
• Primary completion: 2023-08-11
• Completion: 2023-11-08
• First posted: 2022-09-02
• Last updated: 2023-11-13

Locations

12 sites across 1 country: South Korea